Recombinant BCG expressing the LTAK63 adjuvant induces increased early and long-term immune responses against Mycobacteria

The development of more effective vaccines against Mycobacterium tuberculosis has become a world priority. Previously, we have shown that a recombinant BCG expressing the LTAK63 adjuvant (rBCG-LTAK63) displayed higher protection than BCG against tuberculosis challenge in mice. In order to elucidate...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Hum Vaccin Immunother
Главные авторы: Carvalho Dos Santos, Carina, Rodriguez, Dunia, Kanno Issamu, Alex, Cezar De Cerqueira Leite, Luciana, Pereira Nascimento, Ivan
Формат: Artigo
Язык:Inglês
Опубликовано: Taylor & Francis 2019
Предметы:
Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7227645/
https://ncbi.nlm.nih.gov/pubmed/31665996
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1669414
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы